A new approach to tissue rejuvenation

Fount Bio is developing innovative glycopolymer-based products to revitalize tissues. Based on bioorthogonal chemistry, our technology platform overcomes longstanding challenges associated with delivering  glycopolymers to target tissues across a range of applications.

Fount Bio Awarded Prestigious Innovation of the Year at 2024 IMCAS

Fount Bio wins first prize at the Innovation Tank competition for its development of the world’s first platform of products that build crosslinked hyaluronic acid within living tissues

Catch a new wave of innovation

At Fount Bio, we have a bold ambition: to define new categories of high-impact products that generate tremendous value for patients and providers—and tremendous opportunity for our team. Sound like your kind of challenge?